Medical products company settles bribery charges with SEC, again

Stryker Corporation consented to the entry of an order instituting Cease and Desist proceedings for violations of the FCPA’s books and records and internal accounting provisions.  Stryker is alleged to have failed to supervise and enforce its anti-corruption policies and code of conduct in the company’s Indian, Chinese, and Kuwaiti subsidiaries.  The company will pay a $7.8 million penalty.  This is the second time in five years that Stryker has settled FCPA charges.

SEC Press Release | SEC Order